Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Jefferson Research
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Glaxosmithkline Plc Reaffirms FY 2013 EPS Guidance-Conference Call


Wednesday, 24 Jul 2013 09:00am EDT 

Glaxosmithkline Plc announced that for fiscal 2013, it continues to expect core EPS growth of around 3% to 4% and turnover growth of around one 1%, both on a constant currency basis. The Company reported revenue of $42.025 billion and earnings per share (EPS) of $3.53 for fiscal 2012. 

Company Quote

52.51
-0.31 -0.59%
17 Apr 2014